United States

Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference

Saturday, June 12, 2021 - 10:01pm

Incyte (Nasdaq:INCY) today announced that multiple abstracts highlighting updated data for ruxolitinib cream, an investigational topical JAK1/JAK2 inhibitor, in patients with atopic dermatitis (AD) will be presented at the upcoming 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference, held on June 13, 2021.

Key Points: 
  • Incyte (Nasdaq:INCY) today announced that multiple abstracts highlighting updated data for ruxolitinib cream, an investigational topical JAK1/JAK2 inhibitor, in patients with atopic dermatitis (AD) will be presented at the upcoming 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference, held on June 13, 2021.
  • We are pleased to be sharing new data from our Phase 3 TRuE-AD program at the RAD Virtual Conference.
  • These data provide additional insights on the potential role ruxolitinib cream could play as a treatment option for patients living with atopic dermatitis.
  • Ruxolitinib cream is currently in Phase 3 development for the treatment of adolescents and adults with atopic dermatitis (TRuE-AD) and vitiligo (TRuE-V).

Ubisoft Reveals Rocksmith™+, the Future of Interactive Music Learning

Saturday, June 12, 2021 - 9:10pm

Developed by Ubisoft San Francisco, the team behind Rocksmith that provided guitar learning for over 10 years, Rocksmith+ is the only subscription service that offers interactive music learning using official song masters and powerful real-time feedback.

Key Points: 
  • Developed by Ubisoft San Francisco, the team behind Rocksmith that provided guitar learning for over 10 years, Rocksmith+ is the only subscription service that offers interactive music learning using official song masters and powerful real-time feedback.
  • But even the worlds premier music learning software needs to be fine-tuned for the millions of songs coming down the road.
  • Rocksmith+ is the future of interactive music learning; a new subscription service which teaches users how to play guitar and bass through their favorite songs.
  • The Rocksmith logo, Ubisoft and the Ubisoft logo are registered or unregistered trademarks of Ubisoft Entertainment in the US and/or other countries.

Tom Clancy’s Rainbow Six® Extraction Launches on September 16

Saturday, June 12, 2021 - 9:10pm

*

Key Points: 
  • *
    Formerly titled Tom Clancys Rainbow Six Quarantine, Rainbow Six Extraction is being led by a seasoned team of veterans at Ubisoft Montreal.
  • ** Inspired by the long-standing legacy of co-op Rainbow Six shooters, Rainbow Six Extraction is a brand new tactical co-op PvE experience bringing operators together to fight against a mysterious threat.
  • Developed by Ubisoft Montreal, Tom Clancys Rainbow Six Extraction is a one to three-player cooperative tactical first-person shooter.
  • Tom Clancys, Rainbow Six, the Soldier Icon, Ubisoft, and the Ubisoft logo are registered or unregistered trademarks of Ubisoft Entertainment in the US and/or other countries.

Santa Clara University Class of 2021 Delights in Blended Celebration After Year of Uncertainty

Saturday, June 12, 2021 - 9:00pm

Santa Clara University honored its undergraduate Class of 2021 with an in-person celebration and a virtual commencement ceremony over two days this weekend.

Key Points: 
  • Santa Clara University honored its undergraduate Class of 2021 with an in-person celebration and a virtual commencement ceremony over two days this weekend.
  • We are extremely proud of the Class of 2021 for its incredible achievements, said Acting President Lisa Kloppenberg in her virtual address.
  • Santa Clara University Womens Soccer Head Coach Jerry Smith addressed the Class of 2021 during the virtual commencement, a fitting choice following the team's recent NCAA championship win.
  • Continue to rely on your strength of character and your foundation of Jesuit education from Santa Clara University.

Deadline Alert: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Against Romeo Power, Inc.

Saturday, June 12, 2021 - 9:41pm

Investor Deadline Reminder: Investors who purchased or acquired Romeo securities during the Class Period may, no later than June 15, 2021, seek to be appointed as a lead plaintiff representative of the class.

Key Points: 
  • Investor Deadline Reminder: Investors who purchased or acquired Romeo securities during the Class Period may, no later than June 15, 2021, seek to be appointed as a lead plaintiff representative of the class.
  • For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq.
  • Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.

Final Deadline Approaching on June 15, 2021: Kessler Topaz Meltzer & Check, LLP Reminds Credit Suisse Group AG Investors of Class Action Lawsuit Deadline

Saturday, June 12, 2021 - 7:38pm

Credit Suisse investors may, no later than June 15, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member.

Key Points: 
  • Credit Suisse investors may, no later than June 15, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member.
  • Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.
  • For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com .

DNMR CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Danimer Scientific, Inc.

Saturday, June 12, 2021 - 4:11pm

For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq.

Key Points: 
  • For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq.
  • Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.
  • For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com .

Longer-term Data for Kite’s Yescarta® in Relapsed or Refractory Follicular Lymphoma Demonstrate Substantial Survival Improvement Over Current Therapies in Comparative Analysis

Saturday, June 12, 2021 - 3:00pm

We are very encouraged by these data that suggest a significant and sustained survival benefit with Yescarta even after multiple rounds of prior treatment.

Key Points: 
  • We are very encouraged by these data that suggest a significant and sustained survival benefit with Yescarta even after multiple rounds of prior treatment.
  • In an indolent disease like follicular lymphoma, longer-term data that demonstrate durable responses are critical.
  • The continued durable benefit demonstrated by axicabtagene ciloleucel at nearly two years is exciting, and the substantial survival benefit over current therapies that were seeing in the SCHOLAR-5 analysis is encouraging.
  • Adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy.

AHF Offers Solidarity with Orlando Community on ‘Pulse’ Anniversary

Saturday, June 12, 2021 - 10:00am

AIDS Healthcare Foundation (AHF) today offers solidarity and strength with the entire Orlando community as the city marks the fifth anniversary Saturday of the senseless, brutal 2016 Pulse Nightclub attack on the LGBTQ community in Orlando, a city where AHF provides HIV/AIDS care and services including free HIV testing.

Key Points: 
  • AIDS Healthcare Foundation (AHF) today offers solidarity and strength with the entire Orlando community as the city marks the fifth anniversary Saturday of the senseless, brutal 2016 Pulse Nightclub attack on the LGBTQ community in Orlando, a city where AHF provides HIV/AIDS care and services including free HIV testing.
  • The AHF-supported Impulse Group has one of its largest chapters in Orlando, and the Pulse nightclub was one of its major community partners.
  • Today on this most solemn occasion, we offer strength and solidarity to the Orlando community and the entire LGBTQ+ community worldwide.
  • And on New Years Day 2017, AHF paid special tribute to the victims and community of Orlando when it dedicated its annual Rose Parade float entry to Orlando in a float titled To Honor and Remember Orlando.

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Acadia Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Saturday, June 12, 2021 - 4:00am

Investors have until June 18, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until June 18, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Acadia is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.
  • Acadia advised that [t]he notification does not specify the deficiencies identified by the FDA and there has been no clarification by the FDA at this time.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.